[AFAIK]

Limiting vaccine production to those who own patents or licenses makes the vaccine more expensive than it needs to be and also limits supply because instead of utilising the entire world's production capacity to manufacture doses we limit ourselves to a small number of factories in Europe and N America. This bottleneck in production cost millions of lives in Africa during the Aids pandemic and will cost millions of people their lives and livelihoods during the covid-19 epidemic.

If you wish to compensate pharmaceutical companies for acquiring other people's work, conducting trials and then deciding how to package and market the end result then have gov'ts purchase their finished products and release them into the public domain. I find it astonishing that people oppose monopolies that develop organically in retail or transportation but think the gov't should go out of it's way to enforce them when life saving medicines are involved.

[Atlantis]

The US is sitting on tens of millions of doses of AstraZeneca vaccines even though it can't use them because the vaccine hasn't even passed phase 3 trials in the US.

Thousands of people are dying worldwide because the US has banned export of vaccine and vaccine raw materials (@Rugoz, your state of denial is taking on Trumpean proportions).

The U.S. Is Sitting on Tens of Millions of Vaccine Doses the World Needs

AstraZeneca hasn't yet applied for approval of it's vaccine production plant in the Netherlands. That is part of why there is a shortfall of production. Since there is a shortage of raw materials for vaccine production, partly because of the US export ban, delaying approval of its vaccine and plants in the EU, allows AstraZeneca to redirect raw materials to its UK production.

EU’s AstraZeneca vaccine problems linked to mystery factory delay



@AFAIK, I have explained why you are wrong.

[Rugoz]

@Rugoz, your state of denial is taking on Trumpean proportions.

Your distortion of what the articles say is reaching Trumpean proportions.